As part of a series profiling transformational companies and emergent industry trends, the Philadelphia Business Journal has recognized Coriell Institute and its for-profit spinoff venture, Coriell Life Sciences (CLS), as standout organizations.
read moreAlready possessing the largest publicly available collection of human iPS cell lines, Coriell has crossed the 100 iPS cell line threshold and continues to stimulate important biomedical research at the international level.
read moreIn mid-January, Coriell Institute welcomed one of the nation's most influential healthcare reform experts, Dr. Jeffrey Brenner.
read moreAt a summit of the state's most innovative organizations and thought leaders, the New Jersey Technology Council (NJTC) heralded Coriell Life Sciences (CLS) as 2014's top startup company.
read moreScientists from elite institutions all around the country are using biospecimens from the world-renowned Coriell Institute Biobank to conduct meaningful Ebola virus disease research.
read moreA reporter with the Wall Street Journal investigating the relationship between the Ebola virus disease and a rare genetic disorder referenced Coriell's world-renowned biobank.
read moreResearch conducted by Coriell Institute and The Ohio State University (OSU) was featured by a major medical news outlet and also took center stage at a top genetics conference earlier this month.
read moreA team of scientists from Coriell Institute attended the 2014 American Society of Human Genetics (ASHG) annual meeting in San Diego, CA.
read moreJohn P. Sheridan Jr., president and CEO of the Cooper University Health System and a visionary South Jersey business leader, was killed in a house fire early Sunday morning, along with his wife, Joyce.
read moreOfficially launched in late spring, the satellite location is an offshoot of the Institute's gold-standard stem cell and biobanking programs and was created to accommodate a $10M induced pluripotent stem (iPS) cell research grant from the California Institute for Regenerative Medicine (CIRM), a foremost proponent of novel stem cell study.
read more